NHC Submits Comments on CMS Draft Guidance for IPAY 2028
Putting Patients First Blog
JUNE 26, 2025
Even well-intentioned policies can create access disparities if communication and operational support are lacking. The process by which CMS will determine that a drug qualifies for renegotiation should be more transparent. 11 The role of patient-centered evidence in the renegotiation process also requires greater definition.
Let's personalize your content